Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M S Mikhina

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Problemy Endokrinologii|May 18, 2021
[Development of destructive thyroiditis and diabetes mellitus after three injections of pembrolizumab for skin melanoma]A A Glibka, G A Mel Nichenko, M S Mikhina, et al.
Klinicheskaia Meditsina|December 17, 2015
[SPECIFIC CLINICAL FEATURES OF TYPE 1 AUTOIMMUNE POLYGLANDULAR SYNDROME]M S Mikhina, N V Molashenko, E A Troshina, et al.
Problemy Endokrinologii|May 18, 2021
[Clinical practice guidelines for acute and chronic thyroiditis (excluding autoimmune thyroiditis)]E A Troshina, E A Panfilova, M S Mikhina, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Problemy Endokrinologii|May 18, 2021
[Development of destructive thyroiditis and diabetes mellitus after three injections of pembrolizumab for skin melanoma]A A Glibka, G A Mel Nichenko, M S Mikhina, et al.
Klinicheskaia Meditsina|December 17, 2015
[SPECIFIC CLINICAL FEATURES OF TYPE 1 AUTOIMMUNE POLYGLANDULAR SYNDROME]M S Mikhina, N V Molashenko, E A Troshina, et al.
Problemy Endokrinologii|May 18, 2021
[Clinical practice guidelines for acute and chronic thyroiditis (excluding autoimmune thyroiditis)]E A Troshina, E A Panfilova, M S Mikhina, et al.
Pageof 1